A Therapist-guided Online-delivered Group Counseling Program for Pregnant Women and New Mothers With ADHD: A Feasibility Study of AMOR; ADHD, Mothers Online Resources

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The primary aim of this study is to investigate the feasibility of the program AMOR for pregnant women and new mothers with Attention Deficit Hyperactivity Disorder (ADHD), by examining adherence, credibility, treatment satisfaction, and negative effects. The secondary objective is to obtain preliminary information about the short-term clinical outcomes of the program on self-report scales assessing symptoms of ADHD, stress, anxiety, depression, difficulties in emotion regulation, and quality of life. The main questions this study aims to answer: 1. To what extent will pregnant women and new mothers with ADHD adhere to, find useful, be satisfied with, and experience negative effects of the program AMOR? 2. To what extent will pregnant women and new mothers with ADHD experience improvements in ADHD symptoms, stress, anxiety, depression, difficulties in emotion regulation, and quality of life? Participants will: * listen to the 10 podcasts in the program * attend the 10 online guided sessions in the program * fill in questionnaires related to the primary and secondary objectives * some will be invited to participate in an online semi-structured interview

Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Healthy Volunteers: f
View:

• pregnant women or new mothers with an ADHD diagnosis (WHO ICD-10; F90 or F98.8)

• above 18 years

• access to a computer and the internet

• speaks and reads Danish

Locations
Other Locations
Denmark
The Danish ADHD Association
RECRUITING
Odense
Contact Information
Primary
Kathrine Bang Madsen, Associate professor
kbmadsen@health.sdu.dk
+45 23831745
Backup
Katrine Research assistant
kamar@health.sdu.dk
+45 28153422
Time Frame
Start Date: 2025-01-22
Estimated Completion Date: 2025-12-31
Participants
Target number of participants: 30
Treatments
Experimental: Intervention group
Sponsors
Collaborators: Sygeforsikringen danmark
Leads: University of Southern Denmark

This content was sourced from clinicaltrials.gov